351 related articles for article (PubMed ID: 1833542)
21. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
[TBL] [Abstract][Full Text] [Related]
22. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
[TBL] [Abstract][Full Text] [Related]
23. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
24. An immunoradiometric assay for erythrocyte complement (C3b) receptor activity applied to a pediatric population with connective tissue disease.
Buffone GJ; Leatherwood CM; Person DA; Brewer EJ
Clin Chem; 1983 Oct; 29(10):1720-3. PubMed ID: 6616816
[TBL] [Abstract][Full Text] [Related]
25. [The occurrence of defective C3b receptors (CR1) on erythrocytes in connective tissue diseases--their relation to Sjögren's syndrome and SLE].
Inokuma S; Matsumura Y; Kisaki T; Hayakawa T
Ryumachi; 1986 Jun; 26(3):153-8. PubMed ID: 2947339
[No Abstract] [Full Text] [Related]
26. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
27. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
29. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Singh V; Mahoney JA; Petri M
J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
[TBL] [Abstract][Full Text] [Related]
31. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody.
Minota S; Terai C; Nojima Y; Takano K; Takai E; Miyakawa Y; Takaku F
Arthritis Rheum; 1984 Dec; 27(12):1329-35. PubMed ID: 6239627
[TBL] [Abstract][Full Text] [Related]
32. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
33. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
Wilson JG; Wong WW; Schur PH; Fearon DT
N Engl J Med; 1982 Oct; 307(16):981-6. PubMed ID: 7110302
[TBL] [Abstract][Full Text] [Related]
34. CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders.
Iversen BM; Vedeler CA; Matre R; Svarstad E
Nephrol Dial Transplant; 1993; 8(11):1211-4. PubMed ID: 8302457
[TBL] [Abstract][Full Text] [Related]
35. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
Iida K; Mornaghi R; Nussenzweig V
J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
[TBL] [Abstract][Full Text] [Related]
36. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients.
Lach-Trifilieff E; Marfurt J; Schwarz S; Sadallah S; Schifferli JA
J Immunol; 1999 Jun; 162(12):7549-54. PubMed ID: 10358211
[TBL] [Abstract][Full Text] [Related]
37. Lowered expression of C3b receptor (CR1) on erythrocytes of rheumatoid arthritis patients.
Kumar A; Malaviya AN; Srivastava LM
Immunobiology; 1994 Aug; 191(1):9-20. PubMed ID: 7806259
[TBL] [Abstract][Full Text] [Related]
38. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
[TBL] [Abstract][Full Text] [Related]
40. [The role of CR1 complement receptor in pathology].
Rochowiak A; Niemir ZI
Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
